Official websites use .gov
Secure .gov websites use HTTPS
Competition in prescription drug markets, 2017-2022
Competition in prescription drug markets, 2017-2022
- Collection:
- Health Policy and Services Research
- Author(s):
- Parasrampuria, Sonal, author
Murphy, Stephen J. (Stephen James), author - Contributor(s):
- United States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation, issuing body.
- Publication:
- Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services, December 2023
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Drug Costs -- statistics & numerical data
Drug Costs -- trends
Economic Competition
Drug Industry -- economics
Drug Industry -- trends
Prescription Drugs -- economics
United States - Genre(s):
- Technical Report
- Abstract:
- The cornerstone of a well-functioning market is competition. President Biden’s Executive Order 14036, “Promoting Competition in the American Economy” identified a lack of competition as a key driver for problems across economic sectors. By incentivizing competition, it is possible to foster innovation and improve the stability of a market, in turn increasing access and affordability of products. The U.S. prescription drug market is the largest drug market in the world; however, drug prices in the U.S. are much higher than in most of the world. High drug prices mean that people often cannot afford prescription drugs, even when those drugs are otherwise available. We used IQVIA data from 2017 through 2022 to identify the level of competition in different prescription drug markets. We focus on competition in the prescription drug market, because the number of competitors for a particular drug is associated with pricing power – drugs with fewer or only one manufacturer, on average, have higher prices than drugs with multiple manufacturers, holding all else constant. Understanding the baseline level of competition in drug markets will allow us an opportunity to further incentivize innovation and competition.
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (22 pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 9918751487906676 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/9918751487906676